期刊
CANCER CELL INTERNATIONAL
卷 9, 期 -, 页码 -出版社
BMC
DOI: 10.1186/1475-2867-9-20
关键词
-
类别
资金
- Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS)
- program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan
The human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces apoptosis after cell cycle arrest at the G(2) phase in primate cells. We have reported previously that C81, a carboxy-terminally truncated form of Vpr, interferes with cell proliferation and results in apoptosis without G(2) arrest. Here, we investigated whether this property of Vpr and C81 could be exploited for use as a potential anticancer agent. First, we demonstrated that C81 induced G(1) arrest and apoptosis in all tumor cells tested. In contrast, Vpr resulted in G(2) arrest and apoptosis in HeLa and 293 T cells. Vpr also suppressed the damaged-DNA-specific binding protein 1 (DDB1) in HepG2 cells, thereby inducing apoptosis without G(2) arrest. G(2) arrest was restored when DDB1 was overexpressed in cells that also expressed Vpr. Surprisingly, C81 induced G(2) arrest when DDB1 was overexpressed in HepG(2) cells, but not in HeLa or 293 T cells. Thus, the induction of Vpr- and C81-mediated cell cycle arrest appears to depend on the cell type, whereas apoptosis was observed in all tumor cells tested. Overall, Vpr and C81 have potential as novel therapeutic agents for treatment of cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据